The infectious etiology of Alzheimer’s disease

Current Neuropharmacology

Volumn 15, Issue 7, 2017, Pages 996-1009

  Sochocka, Marta ^a   Zwolińska, Katarzyna ^a   Leszek, Jerzy ^b  

^a INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^b WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Alzheimer s disease; Chronic bacterial infections; Chronic viral infections; Neuroinfection; Neuroinflammation; Neurotropic viruses

Indexed keywords

ACETYLCHOLINESTERASE; ACICLOVIR; AMYLOID BETA PROTEIN; CHOLINESTERASE INHIBITOR; DONEPEZIL; IMMUNOGLOBULIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROLINE RICH PROTEIN; VALACICLOVIR;

ALZHEIMER DISEASE; BACTERIAL INFECTION; BORRELIA BURGDORFERI; CANDIDA ALBICANS; CELL INFILTRATION; CHLAMYDIA PNEUMONIAE; CHRONIC INFLAMMATION; DISEASE ASSOCIATION; DISEASE COURSE; EXCITOTOXICITY; FUSOBACTERIUM NUCLEATUM; HELICOBACTER PYLORI; HERPESVIRIDAE; HUMAN; IMMUNE DEFICIENCY; MYCOSIS; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NONHUMAN; PERIODONTITIS; PORPHYROMONAS GINGIVALIS; PREVOTELLA INTERMEDIA; PROTOZOAL INFECTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SIGNAL TRANSDUCTION; TOXOPLASMA GONDII; TREPONEMA DENTICOLA; TREPONEMA PALLIDUM; VIRUS INFECTION; ANIMAL; COMMUNICABLE DISEASE; IMMUNOLOGY; INFLAMMATION; PATHOPHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; COMMUNICABLE DISEASES; HUMANS; INFLAMMATION;

EID: 85029652065     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X15666170313122937     Document Type: Review

References (134)

1. Alzheimer’s Association. Alzheimer’s Disease facts and figures. Alzheimer’s & Dementia, 2015, 11(3), 332.
2. Kumar, A.; Singh, A.; Ekavali, N. A review on Alzheimer’s disease pathophysiology and its management: an update. Pharmacol. Rep., 2015, 67(2), 195-203. [http://dx.doi.org/10.1016/j.pharep.2014. 09.004] [PMID: 25712639]
3. Mawanda, F.; Wallace, R. Can infections cause Alzheimer’s disease? Epidemiol. Rev., 2013, 35, 161-180. [http://dx.doi.org/ 10.1093/epirev/mxs007] [PMID: 23349428]
4. Bourgade, K.; Le Page, A.; Bocti, C.; Witkowski, J.M.; Dupuis, G.; Frost, E.H.; Fulop, T., Jr. Protective effect of amyloid-β peptides against herpes simplex virus-1 infection in a neuronal cell culture model. J. Alzheimers Dis., 2016, 50(4), 1227-1241. [http://dx.doi. org/10.3233/JAD-150652] [PMID: 26836158]
5. White, M.R.; Kandel, R.; Tripathi, S.; Condon, D.; Qi, L.; Taubenberger, J.; Hartshorn, K.L. Alzheimer’s associated β-amyloid protein inhibits influenza A virus and modulates viral interactions with phagocytes. PLoS One, 2014, 9(7), e101364. [http://dx.doi.org/10.1371/journal.pone.0101364] [PMID: 24988208]
6. Leszek, J.; Sochocka, M.; Gąsiorowski, K. Vascular factors and epigenetic modifications in the pathogenesis of Alzheimer’s disease. J. Neurol. Sci., 2012, 323(1-2), 25-32. [http://dx.doi.org/ 10.1016/j.jns.2012.09.010] [PMID: 23026534]
7. Sochocka, M.; Koutsouraki, E.S.; Gasiorowski, K.; Leszek, J. Vascular oxidative stress and mitochondrial failure in the pathobiology of Alzheimer’s disease: a new approach to therapy. CNS Neurol. Disord. Drug Targets, 2013, 12(6), 870-881. [http:// dx.doi.org/10.2174/18715273113129990072] [PMID: 23469836]
8. Heneka, M.T.; Kummer, M.P.; Latz, E. Innate immune activation in neurodegenerative disease. Nat. Rev. Immunol., 2014, 14(7), 463-477. [http://dx.doi.org/10.1038/nri3705] [PMID: 24962261]
9. Li, Y.; Tan, M-S.; Jiang, T.; Tan, L. Microglia in Alzheimer’s disease. BioMed. Res. Int., 2014, 2014, 437483. [PMID: 25197646]
10. Lim, S.L.; Rodriguez-Ortiz, C.J.; Kitazawa, M. Infection, systemic inflammation, and Alzheimer’s disease. Microbes Infect., 2015, 17(8), 549-556. [http://dx.doi.org/10.1016/j.micinf.2015.04.004] [PMID: 25912134]
11. Jacobs, A.H.; Tavitian, B. Noninvasive molecular imaging of neuroinflammation. J. Cereb. Blood Flow Metab., 2012, 32(7), 1393-1415. [http://dx.doi.org/10.1038/jcbfm.2012.53] [PMID: 22549622]
12. Headland, S.E.; Norling, L.V. The resolution of inflammation: Principles and challenges. Semin. Immunol., 2015, 27(3), 149-160. [http://dx.doi.org/10.1016/j.smim.2015.03.014] [PMID: 25911383]
13. Franceschi, C.; Campisi, J. Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. J. Gerontol. A Biol. Sci. Med. Sci., 2014, 69(Suppl 1), S4-S9. [http://dx.doi.org/10.1093/gerona/glu057] [PMID: 24833586]
14. Całkosiński, I.; Dobrzyński, M.; Całkosińska, M.; Seweryn, E.; Bronowicka-Szydełko, A.; Dzierzba, K.; Ceremuga, I.; Gamian, A. [Characterization of an inflammatory response]. Postepy Hig Med Dosw (Online), 2009, 63(3), 395-408. [online]. [PMID: 19745226]
15. Maskrey, B.H.; Megson, I.L.; Whitfield, P.D.; Rossi, A.G. Mechanisms of resolution of inflammation: a focus on cardiovascular disease. Arterioscler. Thromb. Vasc. Biol., 2011, 31(5), 1001-1006. [http://dx.doi.org/10.1161/ATVBAHA.110.213850] [PMID: 21508346]
16. Krstic, D.; Knuesel, I. Deciphering the mechanism underlying lateonset Alzheimer disease. Nat. Rev. Neurol., 2013, 9(1), 25-34. [http://dx.doi.org/10.1038/nrneurol.2012.236] [PMID: 23183882]
17. Bartus, R.T.; Dean, R.L., III; Beer, B.; Lippa, A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science, 1982, 217(4558), 408-414. [http://dx.doi.org/10.1126/science.7046051] [PMID: 7046051]
18. Hardy, J.; Allsop, D. Amyloid deposition as the central event in the aetiology of Alzheimer’s disease. Trends Pharmacol. Sci., 1991, 12(10), 383-388. [http://dx.doi.org/10.1016/0165-6147(91)90609-V] [PMID: 1763432]
19. Heneka, M.T.; Carson, M.J.; El Khoury, J.; Landreth, G.E.; Brosseron, F.; Feinstein, D.L.; Jacobs, A.H.; Wyss-Coray, T.; Vitorica, J.; Ransohoff, R.M.; Herrup, K.; Frautschy, S.A.; Finsen, B.; Brown, G.C.; Verkhratsky, A.; Yamanaka, K.; Koistinaho, J.; Latz, E.; Halle, A.; Petzold, G.C.; Town, T.; Morgan, D.; Shinohara, M.L.; Perry, V.H.; Holmes, C.; Bazan, N.G.; Brooks, D.J.; Hunot, S.; Joseph, B.; Deigendesch, N.; Garaschuk, O.; Boddeke, E.; Dinarello, C.A.; Breitner, J.C.; Cole, G.M.; Golenbock, D.T.; Kummer, M.P. Neuroinflammation in Alzheimer’s disease. Lancet Neurol., 2015, 14(4), 388-405. [http://dx.doi.org/ 10.1016/S1474-4422(15)70016-5] [PMID: 25792098]
20. Morales, I.; Guzman-Martinez, L.; Cerda-Troncoso, C.; Farias, G.A.; Maccioni, R.B. Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches. Front. Cell. Neurosci., 2014, 8, 112. [http://dx.doi.org/10.3389/fncel.2014.00112] [PMID: 24795567]
21. Liddelow, S.A.; Guttenplan, K.A.; Clarke, L.E.; Bennett, F.C.; Bohlen, C.J.; Schirmer, L.; Bennett, M.L.; Munch, A.E.; Chung, W.S.; Peterson, T.C.; Wilton, D.K.; Frouin, A.; Napier, B.A.; Panicker, N.; Kumar, M.; Buckwalter, M.S.; Rowitch, D.H.; Dawson, V.L.; Dawson, T.M.; Stevens, B.; Barres, B.A. Neurotoxic reactive astrocytes are induced by activated microglia. Nature, 2017, 541(7638), 481-487. [http://dx.doi.org/10.1038/ nature21029] [PMID: 28099414]
22. Rosenberg, G.A. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases. Lancet Neurol., 2009, 8(2), 205-216. [http://dx.doi.org/10.1016/S1474-4422(09)70016-X] [PMID: 19161911]
23. Stomrud, E.; Bjorkqvist, M.; Janciauskiene, S.; Minthon, L.; Hansson, O. Alterations of matrix metalloproteinases in the healthy elderly with increased risk of prodromal Alzheimer’s disease. Alzheimers Res. Ther., 2010, 2(3), 20. [http://dx.doi.org/10.1186/ alzrt44] [PMID: 20576109]
24. Mroczko, B.; Groblewska, M.; Barcikowska, M. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study. J. Alzheimers Dis., 2013, 37(2), 273-283. [PMID: 23792694]
25. Brkic, M.; Balusu, S.; Libert, C.; Vandenbroucke, R.E. Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases. Mediators Inflamm., 2015, 2015, 620581. [http://dx.doi.org/10.1155/2015/620581] [PMID: 26538832]
26. Gottschall, P.E.; Deb, S. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons. Neuroimmunomodulation, 1996, 3(2-3), 69-75. [http://dx.doi.org/10.1159/ 000097229] [PMID: 8945720]
27. Deb, S.; Gottschall, P.E. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J. Neurochem., 1996, 66(4), 1641-1647. [http://dx.doi.org/10.1046/j.1471-4159.1996. 66041641.x] [PMID: 8627321]
28. Wang, X.-X.; Tan, M.-S.; Yu, J.-T.; Tan, L. Matrix metalloproteinases and their multiple roles in Alzheimer’s disease. BioMed. Res. Int., 2014, 2014, 908636. [PMID: 25050378]
29. Mizoguchi, H.; Takuma, K.; Fukuzaki, E.; Ibi, D.; Someya, E.; Akazawa, K.H.; Alkam, T.; Tsunekawa, H.; Mouri, A.; Noda, Y.; Nabeshima, T.; Yamada, K. Matrix metalloprotease-9 inhibition improves amyloid beta-mediated cognitive impairment and neurotoxicity in mice. J. Pharmacol. Exp. Ther., 2009, 331(1), 14-22. [http://dx.doi.org/10.1124/jpet.109.154724] [PMID: 19587312]
30. Roubaud Baudron, C.; Varon, C.; Megraud, F.; Salles, N. Alzheimer’s disease: the infectious hypothesis. Geriatr. Psychol. Neuropsychiatr. Vieil., 2015, 13(4), 418-424. [PMID: 26707559]
31. Bu, X-L.; Yao, X.Q.; Jiao, S.S.; Zeng, F.; Liu, Y.H.; Xiang, Y.; Liang, C.R.; Wang, Q.H.; Wang, X.; Cao, H.Y.; Yi, X.; Deng, B.; Liu, C.H.; Xu, J.; Zhang, L.L.; Gao, C.Y.; Xu, Z.Q.; Zhang, M.; Wang, L.; Tan, X.L.; Xu, X.; Zhou, H.D.; Wang, Y.J. A study on the association between infectious burden and Alzheimer’s disease. Eur. J. Neurol., 2015, 22(12), 1519-1525. [http://dx.doi.org/10. 1111/ene.12477] [PMID: 24910016]
32. Licastro, F.; Carbone, I.; Raschi, E.; Porcellini, E. The 21st century epidemic: infections as inductors of neuro-degeneration associated with Alzheimer’s Disease. Immun. Ageing, 2014, 11(1), 22. [http://dx.doi.org/10.1186/s12979-014-0022-8] [PMID: 25516763]
33. Kristen, H.; Santana, S.; Sastre, I.; Recuero, M.; Bullido, M.J.; Aldudo, J. Herpes simplex virus type 2 infection induces AD-like neurodegeneration markers in human neuroblastoma cells. Neurobiol. Aging, 2015, 36(10), 2737-2747. [http://dx.doi.org/10. 1016/j.neurobiolaging.2015.06.014] [PMID: 26163986]
34. Hemling, N.; Roytta, M.; Rinne, J.; Pollanen, P.; Broberg, E.; Tapio, V.; Vahlberg, T.; Hukkanen, V. Herpesviruses in brains in Alzheimer’s and Parkinson’s diseases. Ann. Neurol., 2003, 54(2), 267-271. [http://dx.doi.org/10.1002/ana.10662] [PMID: 12891684]
35. Chiu, W-C.; Tsan, Y-T.; Tsai, S-L.; Chang, C.J.; Wang, J.D.; Chen, P.C. Hepatitis C viral infection and the risk of dementia. Eur. J. Neurol., 2014, 21(8), 1068-e59. [http://dx.doi.org/10.1111/ene.12317] [PMID: 24313931]
36. Bibi, F.; Yasir, M.; Sohrab, S.S.; Azhar, E.I.; Al-Qahtani, M.H.; Abuzenadah, A.M.; Kamal, M.A.; Naseer, M.I. Link between chronic bacterial inflammation and Alzheimer disease. CNS Neurol. Disord. Drug Targets, 2014, 13(7), 1140-1147. [http://dx.doi.org/ 10.2174/1871527313666140917115741] [PMID: 25230225]
37. Wiciński, M.; Sopońska, P.; Brzoszczyk, B.; Malinowski, B.; Grześk, E.; Michalska, A. Role of infection factors in neurodegenerative diseases. Post Microbiol., 2013, pp. 93-103.
38. Miklossy, J. Historic evidence to support a causal relationship between spirochetal infections and Alzheimer’s disease. Front. Aging Neurosci., 2015, 7, 46. [http://dx.doi.org/10.3389/fnagi. 2015.00046] [PMID: 25932012]
39. Miklossy, J. Alzheimer’s disease-a neurospirochetosis. Analysis of the evidence following Koch’s and Hill’s criteria. J. Neuroinflamm., 2011, 8, 90. [http://dx.doi.org/10.1186/1742-2094-8-90] [PMID: 21816039]
40. Olsen, I.; Singhrao, S.K. Can oral infection be a risk factor for Alzheimer’s disease? J. Oral Microbiol., 2015, 7, 29143. [http://dx.doi.org/10.3402/jom.v7.29143] [PMID: 26385886]
41. Alonso, R.; Pisa, D.; Rabano, A.; Rodal, I.; Carrasco, L. Cerebrospinal fluid from Alzheimer’s disease patients contains fungal proteins and DNA. J. Alzheimers Dis., 2015, 47(4), 873-876. [http://dx.doi.org/10.3233/JAD-150382] [PMID: 26401766]
42. Pisa, D.; Alonso, R.; Rabano, A.; Rodal, I.; Carrasco, L. Different brain regions are infected with fungi in Alzheimer’s disease. Sci. Rep., 2015, 5, 15015. [http://dx.doi.org/10.1038/srep15015] [PMID: 26468932]
43. Barichello, T.; Generoso, J.S.; Goularte, J.A.; Collodel, A.; Pitcher, M.R.; Simoes, L.R.; Quevedo, J.; Dal-Pizzol, F. Does infectioninduced immune activation contribute to dementia? Aging Dis., 2015, 6(5), 342-348. [http://dx.doi.org/10.14336/AD.2015.0521] [PMID: 26425389]
44. Chen, W.-W.; Zhang, X.; Huang, W.-J. Role of neuroinflammation in neurodegenerative diseases (Review). Mol. Med. Rep., 2016, 13(4), 3391-3396. [Review]. [PMID: 26935478]
45. Ball, M.J. Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved?. Can. J. Neurol. Sci., 1982, 9(3), 303-306. [http://dx.doi.org/10.1017/S0317167100044115] [PMID: 7116237]
46. Gannicliffe, A.; Sutton, R.N.; Itzhaki, R.F. Viruses, brain and immunosuppression. Psychol. Med., 1986, 16(2), 247-249. [http://dx.doi.org/10.1017/S0033291700009053] [PMID: 3014587]
47. Itzhaki, R.F. Herpes simplex virus type 1 and Alzheimer’s disease: increasing evidence for a major role of the virus. Front. Aging Neurosci., 2014, 6, 202. [http://dx.doi.org/10.3389/fnagi.2014. 00202] [PMID: 25157230]
48. Moreno-Trevino, M.G.; Castillo-Lopez, J.; Meester, I. Moving away from amyloid Beta to move on in Alzheimer research. Front. Aging Neurosci., 2015, 7, 2. [PMID: 25657623]
49. Lin, W.R.; Shang, D.; Wilcock, G.K.; Itzhaki, R.F. Alzheimer’s disease, herpes simplex virus type 1, cold sores and apolipoprotein E4. Biochem. Soc. Trans., 1995, 23(4), 594. [http://dx.doi.org/10. 1042/bst023594s] [PMID: 8654779]
50. Itzhaki, R.F.; Lin, W.R.; Shang, D.; Wilcock, G.K.; Faragher, B.; Jamieson, G.A. Herpes simplex virus type 1 in brain and risk of Alzheimer’s disease. Lancet, 1997, 349(9047), 241-244. [http://dx. doi.org/10.1016/S0140-6736(96)10149-5] [PMID: 9014911]
51. Itzhaki, R.F.; Wozniak, M.A. Could antivirals be used to treat Alzheimer’s disease? Future Microbiol., 2012, 7(3), 307-309. [http://dx.doi.org/10.2217/fmb.12.10] [PMID: 22393884]
52. Wozniak, M.A.; Itzhaki, R.F.; Shipley, S.J.; Dobson, C.B. Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation. Neurosci. Lett., 2007, 429(2-3), 95-100. [http://dx.doi.org/10.1016/j.neulet.2007.09.077] [PMID: 17980964]
53. Wozniak, M.A.; Mee, A.P.; Itzhaki, R.F. Herpes simplex virus type 1 DNA is located within Alzheimer’s disease amyloid plaques. J. Pathol., 2009, 217(1), 131-138. [http://dx.doi.org/10.1002/path.2449] [PMID: 18973185]
54. Lovheim, H.; Gilthorpe, J.; Johansson, A.; Eriksson, S.; Hallmans, G.; Elgh, F. Herpes simplex infection and the risk of Alzheimer’s disease: A nested case-control study. Alzheimers Dement., 2015, 11(6), 587-592. [http://dx.doi.org/10.1016/j.jalz.2014.07.157] [PMID: 25304990]
55. Lovheim, H.; Gilthorpe, J.; Adolfsson, R.; Nilsson, L.G.; Elgh, F. Reactivated herpes simplex infection increases the risk of Alzheimer’s disease. Alzheimers Dement., 2015, 11(6), 593-599. [http://dx.doi.org/10.1016/j.jalz.2014.04.522] [PMID: 25043910]
56. Hu, S.; Sheng, W.S.; Schachtele, S.J.; Lokensgard, J.R. Reactive oxygen species drive herpes simplex virus (HSV)-1-induced proinflammatory cytokine production by murine microglia. J. Neuroinflamm., 2011, 8, 123. [http://dx.doi.org/10.1186/1742-2094-8-123] [PMID: 21943001]
57. Fodor, P.A.; Levin, M.J.; Weinberg, A.; Sandberg, E.; Sylman, J.; Tyler, K.L. Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology, 1998, 51(2), 554-559. [http://dx.doi.org/10.1212/WNL.51.2.554] [PMID: 9710034]
58. Rodriguez-Violante, M.; Ordonez, G.; Bermudez, J.R.; Sotelo, J.; Corona, T. Association of a history of varicella virus infection with multiple sclerosis. Clin. Neurol. Neurosurg., 2009, 111(1), 54-56. [http://dx.doi.org/10.1016/j.clineuro.2008.07.007] [PMID: 18947921]
59. Barnes, L.L.; Capuano, A.W.; Aiello, A.E.; Turner, A.D.; Yolken, R.H.; Torrey, E.F.; Bennett, D.A. Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals. J. Infect. Dis., 2015, 211(2), 230-237. [http://dx.doi.org/10.1093/ infdis/jiu437] [PMID: 25108028]
60. Nimgaonkar, V.L.; Yolken, R.H.; Wang, T.; Chang, C.C.; McClain, L.; McDade, E.; Snitz, B.E.; Ganguli, M. Temporal cognitive decline associated with exposure to infectious agents in a population-based, aging cohort. Alzheimer Dis. Assoc. Disord., 2016, 30(3), 216-222. [http://dx.doi.org/10.1097/WAD.0000000000000133] [PMID: 26710257]
61. Lurain, N.S.; Hanson, B.A.; Martinson, J.; Leurgans, S.E.; Landay, A.L.; Bennett, D.A.; Schneider, J.A. Virological and immunological characteristics of human cytomegalovirus infection associated with Alzheimer disease. J. Infect. Dis., 2013, 208(4), 564-572. [http://dx.doi.org/10.1093/infdis/jit210] [PMID: 23661800]
62. Biesiada, G.; Czepiel, J.; Sobczyk-Krupiarz, I.; Mach, T.; Garlicki, A. Neurological complications among patients with zoster hospitalized in department of infectious diseases in cracow in 2001-2006. Przegl. Lek., 2010, 67(3), 149-150. [PMID: 20687373]
63. Carbone, I.; Lazzarotto, T.; Ianni, M.; Porcellini, E.; Forti, P.; Masliah, E.; Gabrielli, L.; Licastro, F. Herpes virus in Alzheimer’s disease: relation to progression of the disease. Neurobiol. Aging, 2014, 35(1), 122-129. [http://dx.doi.org/10.1016/j.neurobiolaging. 2013.06.024] [PMID: 23916950]
64. Senzolo, M.; Schiff, S.; D’Aloiso, C.M.; Crivellin, C.; Cholongitas, E.; Burra, P.; Montagnese, S. Neuropsychological alterations in hepatitis C infection: the role of inflammation. World J. Gastroenterol., 2011, 17(29), 3369-3374. [http://dx.doi.org/10. 3748/wjg.v17.i29.3369] [PMID: 21876628]
65. Fletcher, N.F.; McKeating, J.A. Hepatitis C virus and the brain. J. Viral Hepat., 2012, 19(5), 301-306. [http://dx.doi.org/10.1111/ j.1365-2893.2012.01591.x] [PMID: 22497808]
66. Grover, V.P.; Pavese, N.; Koh, S-B.; Wylezinska, M.; Saxby, B.K.; Gerhard, A.; Forton, D.M.; Brooks, D.J.; Thomas, H.C.; Taylor-Robinson, S.D. Cerebral microglial activation in patients with hepatitis C: in vivo evidence of neuroinflammation. J. Viral Hepat., 2012, 19(2), e89-e96. [http://dx.doi.org/10.1111/j.1365-2893.2011. 01510.x] [PMID: 22239531]
67. Alzheimer, A. Uber eine eigenartige Erkrankung der Hirnrinde; Allg. Z. Psychiatr. Psych.-Gerichtl. Med, 1907, 64, 146-148.
68. Maheshwari, P.; Eslick, G.D. Bacterial infection and Alzheimer’s disease: a meta-analysis. J. Alzheimers Dis., 2015, 43(3), 957-966. [PMID: 25182736]
69. Christen-Zaech, S.; Kraftsik, R.; Pillevuit, O.; Kiraly, M.; Martins, R.; Khalili, K.; Miklossy, J. Early olfactory involvement in Alzheimer’s disease. Can. J. Neurol. Sci., 2003, 30(1), 20-25. [http://dx.doi.org/10.1017/S0317167100002389] [PMID: 12619779]
70. Hill, J.M.; Lukiw, W.J. Microbial-generated amyloids and Alzheimer’s disease (AD). Front. Aging Neurosci., 2015, 7, 9. [http://dx.doi.org/10.3389/fnagi.2015.00009] [PMID: 25713531]
71. Noguchi, H.; Moore, J.W. A demonstration of treponema pallidum in the brain in cases of general paralysis. J. Exp. Med., 1913, 17(2), 232-238. [http://dx.doi.org/10.1084/jem.17.2.232] [PMID: 19867640]
72. Ramesh, G.; MacLean, A.G.; Philipp, M.T. Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm., 2013, 2013, 480739. [http://dx.doi.org/10.1155/2013/480739] [PMID: 23997430]
73. MacDonald, A.B.; Miranda, J.M. Concurrent neocortical borreliosis and Alzheimer’s disease. Hum. Pathol., 1987, 18(7), 759-761. [http://dx.doi.org/10.1016/S0046-8177(87)80252-6] [PMID: 3297997]
74. Miklossy, J.; Khalili, K.; Gern, L.; Ericson, R.L.; Darekar, P.; Bolle, L.; Hurlimann,J.;Paster,B.J.BorreliaburgdorferipersistsinthebraininchroniclymeneuroborreliosisandmaybeassociatedwithAlzheimerdisease.J.AlzheimersDis.,2004,6,639-649-681.
75. Stanek, G.; Wormser, G.P.; Gray, J.; Strle, F. Lyme borreliosis. Lancet, 2012, 379(9814), 461-473. [http://dx.doi.org/10.1016/ S0140-6736(11)60103-7] [PMID: 21903253]
76. MacDonald, A.B. Alzheimer’s neuroborreliosis with trans-synaptic spread of infection and neurofibrillary tangles derived from intraneuronal spirochetes. Med. Hypotheses, 2007, 68(4), 822-825. [http://dx.doi.org/10.1016/j.mehy.2006.08.043] [PMID: 17055667]
77. Fenno, J.C. Treponema denticola interactions with host proteins. J. Oral Microbiol., 2012, 4, 4. [http://dx.doi.org/10.3402/jom.v4i0. 9929] [PMID: 22368767]
78. Kamer, A.R.; Craig, R.G.; Dasanayake, A.P.; Brys, M.; Glodzik-Sobanska, L.; de Leon, M.J. Inflammation and Alzheimer’s disease: possible role of periodontal diseases. Alzheimers Dement., 2008, 4(4), 242-250. [http://dx.doi.org/10.1016/j.jalz.2007.08.004] [PMID: 18631974]
79. Gurav, A.N. Alzheimer’s disease and periodontitis--an elusive link. Rev. Assoc. Med. Bras., (1992), 2014, 60(2), 173-180. [http://dx. doi.org/10.1590/1806-9282.60.02.015] [PMID: 24919005]
80. Hatipoglu, M.G.; Kabay, S.C.; Guven, G. The clinical evaluation of the oral status in Alzheimer-type dementia patients. Gerodontology, 2011, 28(4), 302-306. [http://dx.doi.org/10.1111/j.1741-2358.2010. 00401.x] [PMID: 21054507]
81. Abbayya, K.; Puthanakar, N.Y.; Naduwinmani, S.; Chidambar, Y.S. Association between Periodontitis and Alzheimer’s Disease. N. Am. J. Med. Sci., 2015, 7(6), 241-246. [http://dx.doi.org/ 10.4103/1947-2714.159325] [PMID: 26199919]
82. Kamer, A.R.; Dasanayake, A.P.; Craig, R.G.; Glodzik-Sobanska, L.; Bry, M.; de Leon, M.J. Alzheimer’s disease and peripheral infections: the possible contribution from periodontal infections, model and hypothesis. J. Alzheimers Dis., 2008, 13(4), 437-449. [http://dx.doi.org/10.3233/JAD-2008-13408] [PMID: 18487851]
83. Ide, M.; Harris, M.; Stevens, A.; Sussams, R.; Hopkins, V.; Culliford, D.; Fuller, J.; Ibbett, P.; Raybould, R.; Thomas, R.; Puenter, U.; Teeling, J.; Perry, V.H.; Holmes, C. Periodontitis and cognitive decline in alzheimer’s Disease. PLoS One, 2016, 11(3), e0151081. [http://dx.doi.org/10.1371/journal.pone.0151081] [PMID: 26963387]
84. Polepalle, T.; Moogala, S.; Boggarapu, S.; Pesala, D.S.; Palagi, F.B. Acute phase proteins and their role in periodontitis: A review. J. Clin. Diagn. Res., 2015, 9(11), ZE01-ZE05. [PMID: 26674303]
85. Sochocka, M.; Sobczyński, M.; Sender-Janeczek, A.; Zwolińska, K.; Błachowicz, O.; Tomczyk, T.; Ziętek, M.; Leszek, J. Association between periodontal health status and cognitive abilities. The role of cytokine profile and systemic inflammation. Curr. Alzheimer Res., in press [Epub ahead of print] [PMID: 28317488]
86. Kamer, A.R.; Craig, R.G.; Pirraglia, E.; Dasanayake, A.P.; Norman, R.G.; Boylan, R.J.; Nehorayoff, A.; Glodzik, L.; Brys, M.; de Leon, M.J. TNF-alpha and antibodies to periodontal bacteria discriminate between Alzheimer’s disease patients and normal subjects. J. Neuroimmunol., 2009, 216(1-2), 92-97. [http://dx.doi. org/10.1016/j.jneuroim.2009.08.013] [PMID: 19767111]
87. Farhad, S.Z.; Amini, S.; Khalilian, A.; Barekatain, M.; Mafi, M.; Barekatain, M.; Rafei, E. The effect of chronic periodontitis on serum levels of tumor necrosis factor-alpha in Alzheimer disease. Dent. Res. J. (Isfahan), 2014, 11(5), 549-552. [PMID: 25426144]
88. Riviere, G.R.; Riviere, K.H.; Smith, K.S. Molecular and immunological evidence of oral Treponema in the human brain and their association with Alzheimer’s disease. Oral Microbiol. Immunol., 2002, 17(2), 113-118. [http://dx.doi.org/10.1046/j.0902-0055.2001.00100.x] [PMID: 11929559]
89. Poole, S.; Singhrao, S.K.; Kesavalu, L.; Curtis, M.A.; Crean, S. Determining the presence of periodontopathic virulence factors in short-term postmortem Alzheimer’s disease brain tissue. J. Alzheimers Dis., 2013, 36(4), 665-677. [PMID: 23666172]
90. Wu, Z.; Nakanishi, H. Connection between periodontitis and Alzheimer’s disease: possible roles of microglia and leptomeningeal cells. J. Pharmacol. Sci., 2014, 126(1), 8-13. [http://dx.doi.org/10.1254/jphs.14R11CP] [PMID: 25168594]
91. Shima, K.; Kuhlenbaumer, G.; Rupp, J. Chlamydia pneumoniae infection and Alzheimer’s disease: a connection to remember? Med. Microbiol. Immunol. (Berl.), 2010, 199(4), 283-289. [http:// dx.doi.org/10.1007/s00430-010-0162-1] [PMID: 20445987]
92. Hammond, C.J.; Hallock, L.R.; Howanski, R.J.; Appelt, D.M.; Little, C.S.; Balin, B.J. Immunohistological detection of Chlamydia pneumoniae in the Alzheimer’s disease brain. BMC Neurosci., 2010, 11, 121. [http://dx.doi.org/10.1186/1471-2202-11-121] [PMID: 20863379]
93. Pollack, D.V.; Croteau, N.L.; Stuart, E.S. Uptake and intrainclusion accumulation of exogenous immunoglobulin by Chlamydia-infected cells. BMC Microbiol., 2008, 8, 213. [http://dx.doi.org/10.1186/1471-2180-8-213] [PMID: 19061499]
94. Takeda, S.; Sato, N.; Morishita, R. Systemic inflammation, bloodbrain barrier vulnerability and cognitive/non-cognitive symptoms in Alzheimer disease: relevance to pathogenesis and therapy. Front. Aging Neurosci., 2014, 6, 171. [http://dx.doi.org/10.3389/fnagi. 2014.00171] [PMID: 25120476]
95. Manabe, T.; Mizukami, K.; Akatsu, H.; Teramoto, S.; Yamaoka, K.; Nakamura, S.; Ohkubo, T.; Kudo, K.; Hizawa, N. Influence of pneumonia complications on the prognosis of patients with autopsy-confirmed Alzheimer’s disease, dementia with Lewy bodies, and vascular dementia. Psychogeriatrics, 2016, 16(5), 305-314. [http://dx.doi.org/10.1111/psyg.12163] [PMID: 26510708]
96. Kountouras, J.; Boziki, M.; Gavalas, E.; Zavos, C.; Deretzi, G.; Grigoriadis, N.; Tsolaki, M.; Chatzopoulos, D.; Katsinelos, P.; Tzilves, D.; Zabouri, A.; Michailidou, I. Increased cerebrospinal fluid Helicobacter pylori antibody in Alzheimer’s disease. Int. J. Neurosci., 2009, 119(6), 765-777. [http://dx.doi.org/10.1080/ 00207450902782083] [PMID: 19326283]
97. Franceschi, F.; Gasbarrini, A.; Polyzos, S.A.; Kountouras, J. Extragastric diseases and Helicobacter pylori. Helicobacter, 2015, 20(Suppl 1), 40-46. [http://dx.doi.org/10.1111/hel.12256] [PMID: 26372824]
98. Poole, S.; Singhrao, S.K.; Chukkapalli, S.; Rivera, M.; Velsko, I.; Kesavalu, L.; Crean, S. Active invasion of Porphyromonas gingivalis and infection-induced complement activation in ApoE-/-mice brains. J. Alzheimers Dis., 2015, 43(1), 67-80. [PMID: 25061055]
99. Alonso, R.; Pisa, D.; Marina, A.I.; Morato, E.; Rabano, A.; Carrasco, L. Fungal infection in patients with Alzheimer’s disease. J. Alzheimers Dis., 2014, 41(1), 301-311. [PMID: 24614898]
100. Wozniak, M.A.; Itzhaki, R.F. Antiviral agents in Alzheimer’s disease: hope for the future? Ther. Adv. Neurol. Disorder., 2010, 3(3), 141-152. [http://dx.doi.org/10.1177/1756285610370069] [PMID: 21179606]
101. Friedman, J.E.; Zabriskie, J.B.; Plank, C.; Ablashi, D.; Whitman, J.; Shahan, B.; Edgell, R.; Shieh, M.; Rapalino, O.; Zimmerman, R.; Sheng, D. A randomized clinical trial of valacyclovir in multiple sclerosis. Mult. Scler., 2005, 11(3), 286-295. [http://dx. doi.org/10.1191/1352458505ms1185oa] [PMID: 15957509]
102. Fillit, H.; Hess, G.; Hill, J.; Bonnet, P.; Toso, C. IV immunoglobulin is associated with a reduced risk of Alzheimer disease and related disorders. Neurology, 2009, 73(3), 180-185. [http://dx.doi. org/10.1212/WNL.0b013e3181ae7aaf] [PMID: 19620605]
103. Licastro, F.; Porcellini, E. Persistent infections, immunesenescence and Alzheimer’s disease. Oncoscience, 2016, 3(5-6), 135-142. [PMID: 27489858]
104. Devi, G.; Schultz, S.; Khosrowshahi, L.; Agnew, A.; Olali, E.; Devi, G. A retrospective chart review of the tolerability and efficacy of intravenous immunoglobulin in the treatment of Alzheimer’s disease. J. Am. Geriatr. Soc., 2008, 56(4), 772-774. [http://dx.doi. org/10.1111/j.1532-5415.2008.01620.x] [PMID: 18380688]
105. Grimaldi, L.M.; Zappala, G.; Iemolo, F.; Castellano, A.E.; Ruggieri, S.; Bruno, G.; Paolillo, A. A pilot study on the use of interferon beta-1a in early Alzheimer’s disease subjects. J. Neuroinflammation, 2014, 11, 30. [http://dx.doi.org/10.1186/1742-2094-11-30] [PMID: 24524367]
106. Alcolea, D.; Martinez-Lage, P.; Sanchez-Juan, P.; Olazaran, J.; Antunez, C.; Izagirre, A.; Ecay-Torres, M.; Estanga, A.; Clerigue, M.; Guisasola, M.C.; Sanchez Ruiz, D.; Marin Munoz, J.; Calero, M.; Blesa, R.; Clarimon, J.; Carmona-Iragui, M.; Morenas-Rodriguez, E.; Rodriguez-Rodriguez, E.; Vazquez Higuera, J.L.; Fortea, J.; Lleo, A. Amyloid precursor protein metabolism and inflammation markers in preclinical Alzheimer disease. Neurology, 2015, 85(7), 626-633. [http://dx.doi.org/10.1212/WNL. 0000000000001859] [PMID: 26180139]
107. Szekely, C.A.; Zandi, P.P. Non-steroidal anti-inflammatory drugs and Alzheimer’s disease: the epidemiological evidence. CNS Neurol. Disord. Drug Targets, 2010, 9(2), 132-139. [http://dx.doi. org/10.2174/187152710791012026] [PMID: 20205647]
108. Yip, A.G.; Green, R.C.; Huyck, M.; Cupples, L.A.; Farrer, L.A. Nonsteroidal anti-inflammatory drug use and Alzheimer’s disease risk: the MIRAGE Study. BMC Geriatr., 2005, 5, 2. [http://dx.doi.org/10.1186/1471-2318-5-2] [PMID: 15647106]
109. Nijhuis, E.; Hinloopen, B.; van Duijn, C.; Hofman, A.; Rozing, J.; Nagelkerken, L. Decreased sensitivity to dexamethasone in lymphocytes from patients with Alzheimer’s disease. Clin. Immunol. Immunopathol., 1994, 73(1), 45-52. [http://dx.doi.org/ 10.1006/clin.1994.1168] [PMID: 7923916]
110. Wang, C-H.; Wang, L-S.; Zhu, N. Cholinesterase inhibitors and non-steroidal anti-inflammatory drugs as Alzheimer’s disease therapies: an updated umbrella review of systematic reviews and meta-analyses. Eur. Rev. Med. Pharmacol. Sci., 2016, 20(22), 4801-4817. [PMID: 27906438]
111. Dregan, A.; Chowienczyk, P.; Armstrong, D. Patterns of antiinflammatory drug use and risk of dementia: a matched casecontrol study. Eur. J. Neurol., 2015, 22(11), 1421-1428. [http://dx.doi.org/10.1111/ene.12774] [PMID: 26177125]
112. Shadfar, S.; Hwang, C.J.; Lim, M-S.; Choi, D-Y.; Hong, J.T. Involvement of inflammation in Alzheimer’s disease pathogenesis and therapeutic potential of anti-inflammatory agents. Arch. Pharm. Res., 2015, 38(12), 2106-2119. [http://dx.doi.org/10.1007/ s12272-015-0648-x] [PMID: 26289122]
113. Newman, D.J.; Cragg, G.M. Advanced preclinical and clinical trials of natural products and related compounds from marine sources. Curr. Med. Chem., 2004, 11(13), 1693-1713. [http://dx.doi.org/10.2174/0929867043364982] [PMID: 15279577]
114. Leszek, J.; Inglot, A.D.; Janusz, M.; Byczkiewicz, F.; Kiejna, A.; Georgiades, J.; Lisowski, J. Colostrinin proline-rich polypeptide complex from ovine colostrum--a long-term study of its efficacy in Alzheimer’s disease. Med. Sci. Monit., 2002, 8(10), PI93-PI96. [PMID: 12388930]
115. Leszek, J.; Inglot, A.D.; Janusz, M.; Lisowski, J.; Krukowska, K.; Georgiades, J.A. Colostrinin: a proline-rich polypeptide (PRP) complex isolated from ovine colostrum for treatment of Alzheimer’s disease. A double-blind, placebo-controlled study. Arch. Immunol. Ther. Exp. (Warsz.), 1999, 47(6), 377-385. [PMID: 10608295]
116. Sochocka, M.; Zaczyńska, E.; Leszek, J.; Siemieniec, I.; Błach-Olszewska, Z. Effect of donepezil on innate antiviral immunity of human leukocytes. J. Neurol. Sci., 2008, 273(1-2), 75-80. [http://dx.doi.org/10.1016/j.jns.2008.06.021] [PMID: 18662817]
117. Jiang, Y.; Zou, Y.; Chen, S.; Zhu, C.; Wu, A.; Liu, Y.; Ma, L.; Zhu, D.; Ma, X.; Liu, M.; Kang, Z.; Pi, R.; Peng, F.; Wang, Q.; Chen, X. The anti-inflammatory effect of donepezil on experimental autoimmune encephalomyelitis in C57 BL/6 mice. Neuropharmacology, 2013, 73, 415-424. [http://dx.doi.org/10. 1016/j.neuropharm.2013.06.023] [PMID: 23831366]
118. Yoshiyama, Y.; Kojima, A.; Ishikawa, C.; Arai, K. Antiinflammatory action of donepezil ameliorates tau pathology, synaptic loss, and neurodegeneration in a tauopathy mouse model. J. Alzheimers Dis., 2010, 22(1), 295-306. [http://dx.doi.org/ 10.3233/JAD-2010-100681] [PMID: 20847440]
119. Kim, H.G.; Moon, M.; Choi, J.G.; Park, G.; Kim, A.J.; Hur, J.; Lee, K.T.; Oh, M.S. Donepezil inhibits the amyloid-beta oligomerinduced microglial activation in vitro and in vivo. Neurotoxicology, 2014, 40, 23-32. [http://dx.doi.org/10.1016/j.neuro.2013.10.004] [PMID: 24189446]
120. Carnevale, D.; De Simone, R.; Minghetti, L. Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems. CNS Neurol. Disord. Drug Targets, 2007, 6(6), 388-397. [http://dx.doi.org/10.2174/ 187152707783399193] [PMID: 18220778]
121. Haddad, J.J.; Saade, N.E.; Safieh-Garabedian, B. Cytokines and neuro-immune-endocrine interactions: a role for the hypothalamicpituitary-adrenal revolving axis. J. Neuroimmunol., 2002, 133(1-2), 1-19. [http://dx.doi.org/10.1016/S0165-5728(02)00357-0] [PMID: 12446003]
122. Reale, M.; Iarlori, C.; Gambi, F.; Lucci, I.; Salvatore, M.; Gambi, D. Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1 beta and interleukin-6 release from lymphocytes of Alzheimer’s disease patients. Exp. Gerontol., 2005, 40(3), 165-171. [http://dx.doi.org/10.1016/j.exger.2004.12.003] [PMID: 15763393]
123. Hwang, J.; Hwang, H.; Lee, H-W.; Suk, K. Microglia signaling as a target of donepezil. Neuropharmacology, 2010, 58(7), 1122-1129. [http://dx.doi.org/10.1016/j.neuropharm.2010.02.003] [PMID: 20153342]
124. Butt, A.M.; Fern, R.F.; Matute, C. Neurotransmitter signaling in white matter. Glia, 2014, 62(11), 1762-1779. [http://dx.doi.org/10. 1002/glia.22674] [PMID: 24753049]
125. Hosli, L.; Hosli, E.; Kaser, H. Colocalization of cholinergic, adrenergic and peptidergic receptors on astrocytes. Neuroreport, 1993, 4(6), 679-682. [http://dx.doi.org/10.1097/00001756-199306000-00019] [PMID: 8394153]
126. Leszek, J.; Basinski, T.; Kiejna, A.; Jutel, M. Donepezil protects monocytes from beta-amyloid-induced death. Neurobiol. Aging, 2004, 25(suppl 2), 434. [http://dx.doi.org/10.1016/S0197-4580(04) 81431-3]
127. Mele, T.; Jurič, D.M. Identification and pharmacological characterization of the histamine H3 receptor in cultured rat astrocytes. Eur. J. Pharmacol., 2013, 720(1-3), 198-204. [http://dx. doi.org/10.1016/j.ejphar.2013.10.028] [PMID: 24432407]
128. Ferreira, R.; Santos, T.; Goncalves, J.; Baltazar, G.; Ferreira, L.; Agasse, F.; Bernardino, L. Histamine modulates microglia function. J. Neuroinflammation, 2012, 9, 90. [http://dx.doi.org/10.1186/ 1742-2094-9-90] [PMID: 22569158]
129. Katoh, Y.; Niimi, M.; Yamamoto, Y.; Kawamura, T.; Morimoto-Ishizuka, T.; Sawada, M.; Takemori, H.; Yamatodani, A. Histamine production by cultured microglial cells of the mouse. Neurosci. Lett., 2001, 305(3), 181-184. [http://dx.doi.org/10.1016/S0304-3940(01)01835-3] [PMID: 11403935]
130. Saxena, G.; Singh, S.P.; Agrawal, R.; Nath, C. Effect of donepezil and tacrine on oxidative stress in intracerebral streptozotocininduced model of dementia in mice. Eur. J. Pharmacol., 2008, 581(3), 283-289. [http://dx.doi.org/10.1016/j.ejphar.2007.12.009] [PMID: 18234183]
131. Meunier, J.; Ieni, J.; Maurice, T. The anti-amnesic and neuroprotective effects of donepezil against amyloid beta25-35 peptide-induced toxicity in mice involve an interaction with the sigma1 receptor. Br. J. Pharmacol., 2006, 149(8), 998-1012. [http://dx.doi.org/10.1038/sj.bjp.0706927] [PMID: 17057756]
132. Itzhaki, R.F.; Lathe, R.; Balin, B.J.; Ball, M.J.; Bearer, E.L.; Braak, H.; Bullido, M.J.; Carter, C.; Clerici, M.; Cosby, S.L.; Del Tredici, K.; Field, H.; Fulop, T.; Grassi, C.; Griffin, W.S.; Haas, J.; Hudson, A.P.; Kamer, A.R.; Kell, D.B.; Licastro, F.; Letenneur, L.; Lovheim, H.; Mancuso, R.; Miklossy, J.; Otth, C.; Palamara, A.T.; Perry, G.; Preston, C.; Pretorius, E.; Strandberg, T.; Tabet, N.; Taylor-Robinson, S.D.; Whittum-Hudson, J.A. Microbes and Alzheimer’s Disease. J. Alzheimers Dis., 2016, 51(4), 979-984. [http://dx.doi.org/10.3233/JAD-160152] [PMID: 26967229]
133. McNamara, J.; Murray, T.A. Connections between herpes simplex virus type 1 and Alzheimer’s disease pathogenesis. Curr. Alzheimer Res., 2016, 13(9), 996-1005. [http://dx.doi.org/10.2174/ 1567205013666160314150136] [PMID: 26971936]
134. O’Connell, D.; Liang, C. Autophagy interaction with herpes simplex virus type-1 infection. Autophagy, 2016, 12(3), 451-459. [http://dx.doi.org/10.1080/15548627.2016.1139262] [PMID: 26934628]